Moreover, a GLP-1 agonist was shown to restore insulin sensitivity and reduce hepatic TC, TG, and LDL-C levels, suggesting the anti-obesity potential of GLP-1 (10, 93). The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.